{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:37:16Z","timestamp":1792888636895,"version":"4.5.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cmi.2025.05.032","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T01:59:53Z","timestamp":1750643993000},"page":"1655-1666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus document"],"prefix":"10.1016","volume":"31","author":[{"given":"Michele","family":"Bartoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Azap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Barac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Ben Selma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onder","family":"Ergonul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effrossyni","family":"Gkrania-Klotsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Antonio","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blin","family":"Nagavci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Pa\u00f1o-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia Camera","family":"Pierrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Sibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balint Gergely","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Tazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Ngai","family":"Yung Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsiodras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Zollner-Schwetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy F.","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.05.032_bib1","doi-asserted-by":"crossref","first-page":"101008","DOI":"10.1016\/j.lanepe.2024.101008","article-title":"Corrigendum to \u2018impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study\u2019 [the Lancet Regional health\u2014Europe 35 (2023) 100747]","volume":"44","author":"Evans","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cmi.2025.05.032_bib2","first-page":"1611","article-title":"COVID-19 hospitalizations up among older adults","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2025.05.032_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmi.2022.10.007","article-title":"The unique presentation of SARS-CoV-2 infection in patients with B-cell depletion: definition of \u2018persistent inflammatory sero-negative COVID\u2019","volume":"29","author":"Belkin","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.05.032_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae308","article-title":"How immunocompromised hosts were left behind in the quest to control the COVID-19 pandemic","volume":"79","author":"Boeckh","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib5","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cmi.2022.08.013","article-title":"European Society of Clinical Microbiology and Infectious Diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild\/moderate disease","volume":"28","author":"Bartoletti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.05.032_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2021.11.007","article-title":"ESCMID COVID-19 living guidelines: drug treatment and clinical management","volume":"28","author":"Bartoletti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.05.032_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cmi.2018.08.005","article-title":"ESCMID white paper: a guide on ESCMID guidance documents","volume":"25","author":"Scudeller","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.05.032_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting Items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2025.05.032_bib10","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2025.05.032_bib11","doi-asserted-by":"crossref","first-page":"101180","DOI":"10.1016\/j.blre.2024.101180","article-title":"Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines","volume":"65","author":"Mikulska","year":"2024","journal-title":"Blood Rev"},{"key":"10.1016\/j.cmi.2025.05.032_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe Covid-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-022-01959-9","article-title":"Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial","volume":"51","author":"Johnson","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.05.032_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.36246","article-title":"Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical trial","volume":"4","author":"Menichetti","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2025.05.032_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-06221-8","article-title":"Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)","volume":"12","author":"van den Berg","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib16","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.2147\/JIR.S378347","article-title":"Remdesivir reduces mortality in hemato-oncology patients with COVID-19","volume":"15","author":"Aksak-W\u0105s","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.cmi.2025.05.032_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143196","article-title":"Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma","volume":"6","author":"Donato","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.cmi.2025.05.032_bib18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/cid\/ciab647","article-title":"Effects of treatment of Coronavirus disease 2019 with convalescent plasma in 25 B-cell-depleted patients","volume":"74","author":"Gharbharan","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cmi.2022.12.016","article-title":"Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir","volume":"29","author":"Martin-Blondel","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.05.032_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18895","article-title":"Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: a multicentre prospective cohort","volume":"202","author":"Minoia","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac502","article-title":"Early outpatient treatment with remdesivir in patients at high risk for severe COVID-19: a prospective cohort study","volume":"9","author":"Rajme-L\u00f3pez","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/vaccines11020200","article-title":"Remdesivir alone or in combination with monoclonal antibodies as an early treatment to prevent severe COVID-19 in patients with mild\/moderate disease at high risk of progression: a single centre, real-life study","volume":"11","author":"Scotto","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cmi.2025.05.032_bib23","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/cid\/ciac324","article-title":"Impact of vaccination and early monoclonal antibody therapy on coronavirus disease 2019 outcomes in organ transplant recipients during the Omicron wave","volume":"75","author":"Solera","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s43440-023-00519-8","article-title":"Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study","volume":"75","author":"Vicente-Valor","year":"2023","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab554","article-title":"Severe acute respiratory syndrome coronavirus 2 monoclonal antibody combination therapy in patients with coronavirus disease 2019 and primary antibody deficiency","volume":"225","author":"Pulvirenti","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003953","article-title":"A programmatic response, including bamlanivimab or casirivimab-imdevimab administration, reduces hospitalization and death in COVID-19 positive abdominal transplant recipients","volume":"106","author":"Ahearn","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2025.05.032_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14032","article-title":"A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19","volume":"34","author":"Ahluwalia","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cmi.2025.05.032_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s44197-023-00084-6","article-title":"Outcome of transplant recipients infected with Omicron BA.1 and BA.2: a single-center retrospective study in Saudi Arabia","volume":"13","author":"Alshukairi","year":"2023","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.cmi.2025.05.032_bib29","doi-asserted-by":"crossref","first-page":"101777","DOI":"10.1016\/j.trim.2022.101777","article-title":"The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19","volume":"77","author":"Arimura","year":"2023","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/hon.3113","article-title":"Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: a retrospective study","volume":"41","author":"Assanto","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib31","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.3389\/ti.2022.10109","article-title":"Initial experience with SARS-CoV-2-neutralizing monoclonal antibodies in kidney or combined kidney-pancreas transplant recipients","volume":"35","author":"Bachmann","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.cmi.2025.05.032_bib32","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.4103\/1319-2442.384188","article-title":"Treatment and outcomes of coronavirus disease 2019 in kidney transplant recipients: a single-center experience","volume":"33","author":"Bansal","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.cmi.2025.05.032_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14037","article-title":"Saving lives with nirmatrelvir\/ritonavir one transplant patient at a time","volume":"25","author":"Belden","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/v13030436","article-title":"Early administration of convalescent plasma improves survival in patients with hematological malignancies and COVID-19","volume":"13","author":"Biernat","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2025.05.032_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac282","article-title":"Real-world experience of sotrovimab in high-risk, immunocompromised COVID-19 patients","volume":"9","author":"Birk","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10082002","article-title":"Safety profile and outcomes of early COVID-19 treatments in immunocompromised patients: a single-centre cohort study","volume":"10","author":"Biscarini","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cmi.2025.05.032_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.403","article-title":"REGEN-COV antibody combination in patients with lymphoproliferative malignancies and SARS-CoV-2 infection","volume":"3","author":"Bronstein","year":"2022","journal-title":"EJHaem"},{"key":"10.1016\/j.cmi.2025.05.032_bib38","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/jha2.554","article-title":"Neutralizing monoclonal antibodies for early treatment of hospital-acquired SARS-CoV-2 infection in hematologic patients","volume":"3","author":"Bussini","year":"2022","journal-title":"EJHaem"},{"key":"10.1016\/j.cmi.2025.05.032_bib39","article-title":"Use and safety of remdesivir in kidney transplant recipients with COVID-19","volume":"6","author":"Buxeda","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib40","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.kint.2022.08.001","article-title":"Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection","volume":"102","author":"Cacho","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2025.05.032_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29082","article-title":"Nirmatrelvir\/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: a real-life experience","volume":"95","author":"Caso","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.cmi.2025.05.032_bib42","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.3390\/cancers14225530","article-title":"Simultaneous onset of haematological malignancy and COVID: an epicovideha survey","volume":"14","author":"Cattaneo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cmi.2025.05.032_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247452","article-title":"Assessing the efficacy of early therapies against SARS-CoV-2 in hematological patients: a real-life study from a COVID-19 referral centre in Northern Italy","volume":"11","author":"Colaneri","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib44","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO International transplant consortium","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2025.05.032_bib45","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.ekir.2022.08.026","article-title":"Safety, efficacy, and relapse of nirmatrelvir-ritonavir in kidney transplant recipients infected with SARS-CoV-2","volume":"7","author":"Devresse","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac565","article-title":"Bebtelovimab for high-risk outpatients with early COVID-19 in a large US health system","volume":"9","author":"Dryden-Peterson","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/M22-2141","article-title":"Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system","volume":"176","author":"Dryden-Peterson","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2022.03.015","article-title":"COVID-19 and kidney transplantation: the impact of remdesivir on renal function and outcome\u2014a retrospective cohort study","volume":"118","author":"Elec","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100470","article-title":"Monoclonal antibody therapy in kidney transplant recipients with Delta and Omicron variants of SARS-CoV-2: a single-center case series","volume":"4","author":"Fernandes","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/cid\/ciac802","article-title":"Rapid selection of sotrovimab escape variants in severe acute respiratory syndrome coronavirus 2 Omicron-infected immunocompromised patients","volume":"76","author":"Gliga","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2021.02.024","article-title":"Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium","volume":"32","author":"Grivas","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib52","article-title":"Early administration of anti-SARS-CoV-2 monoclonal antibodies prevents severe COVID-19 in kidney transplant patients","volume":"7","author":"Gueguen","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/ejhpharm-2022-003544","article-title":"Management of nirmatrelvir\/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series","volume":"31","author":"Guzm\u00e1n Cordero","year":"2024","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.cmi.2025.05.032_bib54","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3390\/v15091952","volume":"15","author":"Hirai","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2025.05.032_bib55","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood.2020008423","article-title":"Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19","volume":"136","author":"Hueso","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.05.032_bib56","first-page":"116","article-title":"Outcomes and management of the SARS-CoV2 Omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy","volume":"30","author":"Infante","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.05.032_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9088393","article-title":"A comprehensive comparison of clinical presentation and outcomes of kidney transplant recipients with COVID-19 during wave 1 versus wave 2 at a tertiary care center, India","volume":"2022","author":"Jasuja","year":"2022","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.cmi.2025.05.032_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad287","article-title":"Real-world effectiveness of nirmatrelvir\/ritonavir on coronavirus disease 2019-associated hospitalization prevention: a population-based cohort study in the province of Qu\u00e9bec, Canada","volume":"77","author":"Kabor\u00e9","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10122490","article-title":"Single center experience using monoclonal COVID-19 antibodies in the management of immunocompromised patients with COVID-19","volume":"10","author":"Klank","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.cmi.2025.05.032_bib60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s15010-022-01914-8","article-title":"Outcome of lung transplant recipients infected with SARS-CoV-2\/Omicron\/B.1.1.529: a Nationwide German study","volume":"51","author":"Kneidinger","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.05.032_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13662","article-title":"Initial experience of bamlanivimab monotherapy use in solid organ transplant recipients","volume":"23","author":"Kutzler","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkac253","article-title":"Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19","volume":"77","author":"Lafont","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.05.032_bib63","doi-asserted-by":"crossref","first-page":"15357","DOI":"10.1038\/s41598-023-42727-5","article-title":"Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study","volume":"13","author":"Lahouati","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/hon.3060","article-title":"Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: an Italian retrospective study","volume":"40","author":"Lanza","year":"2022","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001296","article-title":"One year into the pandemic: evolving COVID-19 outcomes in lung transplant recipients, a single-center experience","volume":"8","author":"Laothamatas","year":"2022","journal-title":"Transplant Direct"},{"key":"10.1016\/j.cmi.2025.05.032_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14540","article-title":"Predictors and outcomes of respiratory failure among lung transplant patients with COVID-19","volume":"36","author":"Lawrence","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cmi.2025.05.032_bib67","article-title":"Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients","volume":"23","author":"Lee","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/10428194.2021.1966782","article-title":"COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome","volume":"62","author":"Levy","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cmi.2025.05.032_bib69","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-022-04924-6","article-title":"Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies","volume":"101","author":"Magyari","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18385","article-title":"Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: the GIMEMA EMATO-0321 study","volume":"199","author":"Marasco","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9636624","article-title":"Management of COVID-19 in kidney transplant recipients: a single-center case series","volume":"2022","author":"Marbun","year":"2022","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.cmi.2025.05.032_bib72","article-title":"Use of remdesivir for COVID-19 in patients with hematologic cancer","volume":"23","author":"Martin-Onra\u00ebt","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18690","article-title":"Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders","volume":"201","author":"Mikulska","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.835770","article-title":"Risk factors for severe COVID-19 and hospital admission in patients with inborn errors of immunity\u2014results from a multicenter nationwide study","volume":"13","author":"Milota","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab875","article-title":"Remdesivir treatment in hospitalized patients with Coronavirus disease 2019 (COVID-19): a comparative analysis of in-hospital all-cause mortality in a large multicenter observational cohort","volume":"75","author":"Mozaffari","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13451","article-title":"Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy","volume":"23","author":"Naeem","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10721","article-title":"Outcome of COVID-19 in kidney transplant recipients through the SARS-CoV-2 variants eras: role of anti-SARS-CoV-2 monoclonal antibodies","volume":"35","author":"Papadimitriou-Olivgeris","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.cmi.2025.05.032_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-023-01994-0","article-title":"Use and effectiveness of remdesivir for the treatment of patients with Covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study","volume":"51","author":"Pilgram","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.05.032_bib79","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/ajt.17098","article-title":"Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge","volume":"22","author":"Radcliffe","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2025.05.032_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247342","article-title":"The course of COVID-19 in patients with systemic autoimmune rheumatic diseases","volume":"11","author":"Rorat","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib81","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001268","article-title":"Outcomes of SOT recipients with COVID-19 in different eras of COVID-19 therapeutics","volume":"8","author":"Sait","year":"2022","journal-title":"Transplant Direct"},{"key":"10.1016\/j.cmi.2025.05.032_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106952","article-title":"Molnupiravir compared to nirmatrelvir\/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry","volume":"62","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2025.05.032_bib83","doi-asserted-by":"crossref","DOI":"10.1590\/2175-8239-jbn-2021-0164","article-title":"SARS-CoV-2 infection in kidney transplant recipients: clinical impact and outcomes\u2014a single center experience","volume":"44","author":"Santos","year":"2022","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.cmi.2025.05.032_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13759","article-title":"Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients","volume":"24","author":"Sarrell","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib85","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-021-01700-2","article-title":"Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?","volume":"18","author":"Shafiekhani","year":"2021","journal-title":"Virol J"},{"key":"10.1016\/j.cmi.2025.05.032_bib86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajt.2022.12.004","article-title":"Paxlovid associated with decreased hospitalization rate among adults with COVID-19\u2014United States, April-September 2022","volume":"23","author":"Shah","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2025.05.032_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxac008","article-title":"Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK","volume":"209","author":"Shields","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib88","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.1799","article-title":"Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19","volume":"7","author":"Thompson","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.34067\/KID.0005732021","article-title":"SARS-CoV-2 neutralizing monoclonal antibodies for the treatment of COVID-19 in kidney transplant recipients","volume":"3","author":"Wang","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.cmi.2025.05.032_bib90","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac916","article-title":"Predictors of coronavirus disease 2019 hospitalization after sotrovimab in patients with hematologic malignancy during the BA.1 omicron surge","volume":"76","author":"Yan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib91","doi-asserted-by":"crossref","first-page":"ofab255","DOI":"10.1093\/ofid\/ofab255","article-title":"Monoclonal antibody therapy for COVID-19 in solid organ transplant recipients","volume":"8","author":"Yetmar","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib92","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac204","article-title":"Outcomes of B-cell-depleted patients with Coronavirus disease 2019 treated with antispike monoclonal antibodies","volume":"9","author":"Yetmar","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2021.12.014","article-title":"COVID-19 in recent lung transplant recipients: clinical outcomes and management strategies","volume":"54","author":"Zimmermann","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cmi.2025.05.032_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2020.08.042","article-title":"Coronavirus disease 2019 viremia, serologies, and clinical course in a case series of transplant recipients","volume":"52","author":"Christensen","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cmi.2025.05.032_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13477","article-title":"Treatment of immunocompromised COVID-19 patients with convalescent plasma","volume":"23","author":"Fung","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18450","article-title":"Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents","volume":"199","author":"Gachoud","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108723","article-title":"Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products","volume":"227","author":"Kenig","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib98","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5114\/ceji.2022.124079","article-title":"Mild to moderate clinical course of COVID-19 infection in patients with common variable immune deficiency","volume":"47","author":"Lesichkova","year":"2022","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib99","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.936832","article-title":"Clinical outcomes of sotrovimab treatment in 10 high-risk patients with mild COVID-19: a case series","volume":"23","author":"Takeda","year":"2022","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13629","article-title":"Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: a retrospective cohort from a developing nation","volume":"23","author":"Meshram","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib101","doi-asserted-by":"crossref","first-page":"899","DOI":"10.6002\/ect.2021.0188","article-title":"Clinical profiles and outcomes of COVID-19 in kidney transplant recipients: experience from a high-volume public sector transplant center in India","volume":"19","author":"Kute","year":"2021","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.cmi.2025.05.032_bib102","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","volume":"10","author":"Chai","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2025.05.032_bib103","article-title":"Convalescent plasma for people with COVID-19: a living systematic review","volume":"5","author":"Iannizzi","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2025.05.032_bib104","doi-asserted-by":"crossref","first-page":"100588","DOI":"10.1016\/j.trre.2020.100588","article-title":"COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature","volume":"35","author":"Raja","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.cmi.2025.05.032_bib105","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad504","article-title":"Characteristics and outcomes of US veterans with immunocompromised conditions at high risk of SARS-CoV-2 infection with or without receipt of oral antiviral agents","volume":"78","author":"Gentry","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib106","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.2147\/DDDT.S369473","article-title":"Impact of remdesivir on SARS-CoV-2 clearance in a real-life setting: a matched-cohort study","volume":"16","author":"Spagnuolo","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.cmi.2025.05.032_bib107","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/ckj\/sfac177","article-title":"Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients","volume":"15","author":"Villanego","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.cmi.2025.05.032_bib108","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.cmi.2023.05.013","article-title":"Viral dynamics of SARS-CoV-2 in immunocompromised patients","volume":"29","author":"Utzon","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.05.032_bib109","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2169\/internalmedicine.0485-22","article-title":"Favorable outcome following sotrovimab monoclonal antibody in a patient with prolonged SARS-CoV-2 omicron infection with HIV\/AIDS","volume":"61","author":"Adachi","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib110","article-title":"Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T","volume":"117","author":"Ambati","year":"2023","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib111","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2025.05.032_bib112","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient","volume":"223","author":"Baang","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab868","article-title":"Persistent coronavirus disease 2019 (COVID-19) in an immunocompromised host treated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific monoclonal antibodies","volume":"74","author":"Bailly","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.945060","article-title":"Case report: long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: the emerging therapeutic role of casirivimab\/imdevimab","volume":"12","author":"Ballotta","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib115","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad189","article-title":"Successful treatment of prolonged severe acute respiratory syndrome coronavirus 2 infection in patients with immunodeficiency with extended nirmatrelvir\/ritonavir: case series","volume":"10","author":"Breeden","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib116","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1038\/s41467-020-19761-2","article-title":"Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report","volume":"11","author":"Buckland","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2025.05.032_bib117","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijid.2020.12.050","article-title":"Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir","volume":"104","author":"Camprubi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib118","article-title":"Relapsing COVID-19 in a patient with non-Hodgkin lymphoma on chemotherapy","volume":"15","author":"Carujo","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.cmi.2025.05.032_bib119","article-title":"Efficacy of convalescent plasma therapy in immunocompromised patients with COVID-19: a case report","volume":"12","author":"Casarola","year":"2021","journal-title":"Clin Infect Pract"},{"key":"10.1016\/j.cmi.2025.05.032_bib120","doi-asserted-by":"crossref","DOI":"10.14740\/jh845","article-title":"COVID-19-associated pneumonia in a B-cell-depleted patient with non-Hodgkin lymphoma: recovery with hyperimmune plasma","volume":"11","author":"Colombo","year":"2022","journal-title":"J Hematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib121","first-page":"101560","article-title":"Successful treatment of prolonged COVID-19 with bamlanivimab in a patient with severe B-cell aplasia due to treatment with an anti-CD20 monoclonal antibody: a case report","volume":"34","author":"Daher","year":"2021","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/v13071202","article-title":"Successful clearance of 300 day SARS-CoV-2 infection in a subject with B-cell depletion associated prolonged (B-DEAP) COVID by REGEN-COV anti-spike monoclonal antibody cocktail","volume":"13","author":"Drouin","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2025.05.032_bib123","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/v14081757","article-title":"Persistent fever and positive PCR 90 days post-SARS-CoV-2 infection in a rituximab-treated patient: a case of late antiviral treatment","volume":"14","author":"Ertesv\u00e5g","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2025.05.032_bib124","doi-asserted-by":"crossref","DOI":"10.48101\/ujms.v128.9807","article-title":"Persistent SARS-CoV-2 infection in patients with B-cell deficiency: a case series of successful antiviral treatment of four patients","volume":"128","author":"Fax\u00e9n","year":"2023","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.cmi.2025.05.032_bib125","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/cid\/ciac868","article-title":"Successful treatment of prolonged, severe coronavirus disease 2019 lower respiratory tract disease in a B cell acute lymphoblastic leukemia patient with an extended course of remdesivir and nirmatrelvir\/ritonavir","volume":"76","author":"Ford","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib126","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-023-02039-2","article-title":"Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab","volume":"51","author":"Franceschini","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.05.032_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763412","article-title":"COVID-19 in B cell-depleted patients after rituximab: a diagnostic and therapeutic challenge","volume":"12","author":"Furlan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib128","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2025.05.032_bib129","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-023-02116-6","article-title":"Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation","volume":"52","author":"Glueck","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.05.032_bib130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkac433","article-title":"Successful use of nirmatrelvir\/ritonavir in immunocompromised patients with persistent and\/or relapsing COVID-19","volume":"78","author":"Graziani","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.05.032_bib131","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"Helleberg","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib132","article-title":"COVID-19 Genomics UK (COG-UK) consortium. Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: retrospective cohort study and literature review","volume":"16","author":"Hettle","year":"2022","journal-title":"Clin Infect Pract"},{"key":"10.1016\/j.cmi.2025.05.032_bib133","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.medj.2023.08.001","article-title":"Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2","volume":"4","author":"Hirotsu","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib134","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkad144","article-title":"High-titer convalescent plasma plus nirmatrelvir\/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients","volume":"78","author":"Huygens","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.05.032_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2023.e01890","article-title":"Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma","volume":"34","author":"Jung","year":"2023","journal-title":"IDCases"},{"key":"10.1016\/j.cmi.2025.05.032_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645989","article-title":"Case report: convalescent plasma achieves SARS-CoV-2 viral clearance in a patient with persistently high viral replication over 8 weeks due to severe combined immunodeficiency (SCID) and graft failure","volume":"12","author":"Keitel","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib137","article-title":"Viral shedding and persistence of anosmia and ageusia in an asymptomatic SARS-CoV-2 infection","volume":"15","author":"Kintrilis","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.cmi.2025.05.032_bib138","article-title":"An atypical case of prolonged COVID-19 infection","volume":"14","author":"Lewis","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.cmi.2025.05.032_bib139","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/23744235.2023.2223274","article-title":"Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir\/ritonavir courses: a case report","volume":"55","author":"Lindahl","year":"2023","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.cmi.2025.05.032_bib140","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3390\/antibiotics12091460","article-title":"Sequential or combination treatments as rescue therapies in immunocompromised patients with persistent SARS-CoV-2 infection in the omicron era: a case series","volume":"12","author":"Longo","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2025.05.032_bib141","doi-asserted-by":"crossref","first-page":"ofab335","DOI":"10.1093\/ofid\/ofab335","article-title":"Successful treatment of persistent coronavirus disease 2019 infection in a patient with hypogammaglobulinemia with REGN-COV2: a case report","volume":"8","author":"Luitel","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib142","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1637","article-title":"Sustained response after remdesivir and convalescent plasma therapy in a B-cell-depleted patient with protracted coronavirus disease 2019 (COVID-19)","volume":"73","author":"Malsy","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib143","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2023.04.412","article-title":"Combination regimen of nirmatrelvir\/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature","volume":"133","author":"Marangoni","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib144","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac382","article-title":"Extended remdesivir infusion for persistent coronavirus disease 2019 infection","volume":"9","author":"Martinez","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib145","doi-asserted-by":"crossref","DOI":"10.1159\/000521121","article-title":"Management of persistent SARS-CoV-2 infection in patients with follicular lymphoma","volume":"145","author":"Mart\u00ednez-Barranco","year":"2022","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cmi.2025.05.032_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860891","article-title":"Persistence of SARS-CoV-2 infection in severely immunocompromised patients with complete remission B-cell lymphoma and anti-CD20 monoclonal antibody therapy: a case report of two cases","volume":"13","author":"Mart\u00ednez-Chinchilla","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2023.10.022","article-title":"Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects","volume":"30","author":"Meijer","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.cmi.2025.05.032_bib148","first-page":"131","article-title":"More than a \u2018Hundred Days war\u2019: persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitis","volume":"7","author":"Mendel","year":"2022","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"10.1016\/j.cmi.2025.05.032_bib149","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with 2 antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients","volume":"77","author":"Mikulska","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.7294","article-title":"Hospital-at-home care for immunodeficient patients with COVID-19: approach to persistent COVID-19 infection","volume":"11","author":"Miyamoto","year":"2023","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib151","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jiac.2022.03.002","article-title":"Successful use of casirivimab\/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19","volume":"28","author":"Miyazato","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.cmi.2025.05.032_bib152","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab295","article-title":"Persistent severe acute respiratory syndrome coronavirus 2 infection in immunocompromised host displaying treatment induced viral evolution","volume":"8","author":"Monrad","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib153","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000003179","article-title":"Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV","volume":"36","author":"Montejano","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2025.05.032_bib154","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7883\/yoken.JJID.2022.092","article-title":"Casirivimab\/imdevimab for active COVID-19 pneumonia which persisted for nine months in a patient with follicular lymphoma during anti-CD20 therapy","volume":"75","author":"Nagai","year":"2022","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/medicina59010108","article-title":"A case of a malignant lymphoma patient persistently infected with SARS-CoV-2 for more than 6 months","volume":"59","author":"Nagasaki","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.cmi.2025.05.032_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2023.05.003","article-title":"Prolonged infective SARS-CoV-2 omicron variant shedding in a patient with diffuse large B cell lymphoma successfully cleared after three courses of remdesivir","volume":"29","author":"Nakamura","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.cmi.2025.05.032_bib157","article-title":"Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity","volume":"12","author":"Nguyen","year":"2021","journal-title":"Clin Infect Pract"},{"key":"10.1016\/j.cmi.2025.05.032_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2021.07.064","article-title":"Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia","volume":"110","author":"Palomba","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/hon.3206","article-title":"Dual combined antiviral treatment with remdesivir and nirmatrelvir\/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection","volume":"41","author":"Pasquini","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib160","article-title":"Nirmatrelvir\/ritonavir as a potential treatment for prolonged SARS-CoV-2 infection in immunocompromised patients","volume":"35","author":"P\u00e9rez Catal\u00e1n","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.cmi.2025.05.032_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28865","article-title":"Antiviral treatment or mAbs for persistent SARS-COV-2 infection in patients with hematologic malignancies: a case series","volume":"95","author":"P\u00e9rez Catal\u00e1n","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.cmi.2025.05.032_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.891274","article-title":"Case report: successful treatment with monoclonal antibodies in one APDS patient with prolonged SARS-CoV-2 infection not responsive to previous lines of treatment","volume":"13","author":"Rivalta","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.05.032_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.tracli.2021.04.004","article-title":"COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?","volume":"28","author":"Rnjak","year":"2021","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.cmi.2025.05.032_bib164","doi-asserted-by":"crossref","first-page":"e6548","DOI":"10.1002\/ccr3.6548","article-title":"Successful treatment of persistent and severe SARS-CoV-2 infection in a high-risk chronic lymphocytic leukemia patient using Ronapreve\u2122 antibodies","volume":"10","author":"Seganfredo","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib165","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.2169\/internalmedicine.0241-22","article-title":"Persistent SARS-CoV-2 infection in a patient with nephrotic syndrome under rituximab therapy: successful treatment with a combination of remdesivir and monoclonal antibodies","volume":"61","author":"Shimizu","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.cmi.2025.05.032_bib166","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.1099","article-title":"A case of prolonged COVID-19 treated with tixagevimab\/cilgavimab","volume":"11","author":"Shimizu","year":"2023","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.cmi.2025.05.032_bib167","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/nep.14235","article-title":"Protracted COVID-19 pneumonitis early post-ABO incompatible kidney transplantation: management considerations and the role of whole genome sequencing","volume":"28","author":"Stoler","year":"2023","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cmi.2025.05.032_bib168","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12941-021-00491-2","article-title":"Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy","volume":"20","author":"Taha","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.cmi.2025.05.032_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17149","article-title":"Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2","volume":"9","author":"Tayar","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.cmi.2025.05.032_bib170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13756-022-01067-1","article-title":"Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values","volume":"11","author":"Thornton","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2025.05.032_bib171","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac847","article-title":"Dual antiviral therapy for persistent coronavirus disease 2019 and associated organizing pneumonia in an immunocompromised host","volume":"76","author":"Trottier","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib172","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1100","article-title":"SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review","volume":"14","author":"Haradaa","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.cmi.2025.05.032_bib173","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000521086","article-title":"The impact of routine molecular screening for SARS-CoV-2 in patients receiving anticancer therapy: an interim analysis of the observational COICA study","volume":"100","author":"Di Lorenzo","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.cmi.2025.05.032_bib174","article-title":"Oncological surgery during the COVID-19 pandemic: effectiveness of preoperative screening and factors associated with postoperative SARS-CoV-2 infection","volume":"29","author":"Lopes","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib175","article-title":"Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant","author":"Campbell","year":"201561192","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib176","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14110","article-title":"When you need to dive in the deep end-Transplanting SARS-CoV-2 PCR+ recipients","volume":"25","author":"Zavala","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.05.032_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100610","article-title":"Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future","volume":"7","author":"Geukens","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.cmi.2025.05.032_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00573-8","article-title":"Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study","volume":"22","author":"Pinato","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cmi.2025.05.032_bib179","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4140\/TCP.n.2021.365","article-title":"Anticancer therapy in COVID-19 patients: a descriptive literature review","volume":"36","author":"Tripathi","year":"2021","journal-title":"Sr Care Pharm"},{"key":"10.1016\/j.cmi.2025.05.032_bib180","doi-asserted-by":"crossref","DOI":"10.1007\/s40487-023-00247-2","article-title":"Early systemic anti-neoplastic treatment post SARS-CoV-2 infection in patients with breast cancer","volume":"11","author":"Halpern","year":"2023","journal-title":"Oncol Ther"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25002812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25002812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:22:33Z","timestamp":1790821353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25002812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":179,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1198743X25002812"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.05.032","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus document","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}